Xiao-Feng Yang
Affiliations: | Pharmacology | Temple University, Philadelphia, PA, United States |
Area:
Immunology, Physiology Biology, Cell BiologyGoogle:
"Xiao-Feng Yang"Children
Sign in to add trainee| Jietang Mai | grad student | 2014 | Temple University |
| Anthony Virtue | grad student | 2014 | Temple University |
| Xinyu Xiong | grad student | 2014 | Temple University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jan M, Cueto R, Jiang X, et al. (2021) Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells. Redox Biology. 102018 |
| Sun Y, Lu Y, Saredy J, et al. (2020) ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes. Redox Biology. 101696 |
| Sun L, Yang X, Yuan Z, et al. (2020) Metabolic Reprogramming in Immune Response and Tissue Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314037 |
| Saaoud F, Wang J, Iwanowycz S, et al. (2020) Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice. Redox Biology. 101609 |
| Shao Y, Saredy J, Yang WY, et al. (2020) Vascular Endothelial Cells and Innate Immunity. Arteriosclerosis, Thrombosis, and Vascular Biology. 40: e138-e152 |
| Zhong C, Yang X, Feng Y, et al. (2020) Trained Immunity: An Underlying Driver of Inflammatory Atherosclerosis. Frontiers in Immunology. 11: 284 |
| Lai B, Wang J, Fagenson A, et al. (2019) Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors. Frontiers in Immunology. 10: 2612 |
| Li X, Fang P, Sun Y, et al. (2019) Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells. Redox Biology. 28: 101373 |
| Chen J, Zhang J, Shaik NF, et al. (2019) The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase. The Journal of Biological Chemistry |
| Zhang L, Wang X, Cueto R, et al. (2019) Biochemical basis and metabolic interplay of redox regulation. Redox Biology. 26: 101284 |